Dental Anesthesia Market Research Report - Forecast to 2027

Global Dental Anesthesia Market Information, Product Type (Lidocaine, Mepivacaine, Prilocaine, Bupivacaine), Types of Anesthesia (General, Local), Mode of Administration (Maxillary, Mandibular), End-User (Specialized Dental Hospitals) Forecast to 2027

ID: MRFR/Pharma/0271-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Anesthesia are drugs inducing sensation loss that is reversible in nature. These drugs are different from painkillers or analgesics that relieve pain without the loss of sensation. According to the World Health Organization (WHO), about 60 to 90% of children suffer from dental caries. The two vasoconstrictors molecules, namely, epinephrine and levonordefrin are distributed widely in the U.S. Prilocaine, articaine, bupivacaine, and lidocaine are some of the epinephrine used as dental anesthetics.


The increasing trend towards dental health checkup, growing investments in dental research, advanced drug administration devices, growing economy, and increasing dental healthcare base are some factors responsible for the growth of this market. Moreover, the introduction of new products and the increasing geriatric population are anticipated to upsurge the market for global dental anesthesia. The stringent regulations by government, usage of traditional therapies, and ignorance to dental problems are anticipated to act as the restraints to the market.


The stringent regulatory requirements due to strict regulatory guidelines, availability of skilled anesthesiologist, and side effects of anesthetic drugs may affect the growth of the global dental anesthetic market.


The global market for Dental Anesthesia diagnosis and treatment is expected to grow at a CAGR of approximately 8.9% during the forecast period 2017–2023.


Intended Audience



  • Dental anesthesia manufacturing companies

  • Suppliers and distributors of dental anesthesia

  • Healthcare service providers

  • Hospitals and Academic Medical Centers (AMCs)

  • Health insurance players

  • Research and consulting firms

  • Medical research institutes

  • Venture capitalists

  • Community centers


Segmentation


The global dental anesthesia market is segmented on the basis of product type, types of anesthesia, route of administration, and end-user.


On the basis of product type, the global dental anesthesia market is segmented into Lidocaine, Mepivacaine, Prilocaine, Bupivacaine 0.5% with Epinephrine 1:200,000, Articaine, and others. The Lidocaine is divided into Lidocaine 2% with Epinephrine 1:100,000, Lidocaine 2% with Epinephrine 1:50,000, and Lidocaine Plain. The mepivacaine is divided into mepivacaine 2% with levonordefrin 1:20,000 and mepivacaine 3%. The prilocaine is divided into prilocaine 4% with epinephrine 1:200,000 and prilocaine 4%. The articaine is divided into articaine 4% with epinephrine 1:100,00 and articaine 4% with epinephrine 1:200,000.


On the basis of type of anesthesia, the global Dental Anesthesia market is segmented into general anesthetics, local anesthetics, and others.


On the basis of the mode of administration, the global dental anesthesia market is segmented into maxillary anesthesia, mandibular anesthesia, and others. The maxillary anesthesia is categorized into local infiltration, field block, asnd nerve block. The local infiltration is further classified into supraperiosteal injection, intraseptal injection, and periodontal ligament injection. The field block is further classified into periapical injection. The nerve block is further classified into posterior superior alveolar, middle superior alveolar, and anterior superior alveolar.


The Mandibular anesthesia is categorized into nerve block, tissue, or skin. The nerve block is further classified into IAN, Akinosi, and Gow-Gates.


On the basis of end-user, the global dental anesthesia market is segmented into specialized dental hospitals, dental clinics, pharmacies and drug stores, e-commerce, and others.


Research Methodology


 dental anesthesia market


Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis


The global dental anesthesia market consists of countries, namely, America, Europe, Asia Pacific, and the Middle East and Africa.


Americas dominated the global dental anesthesia market owing to the increasing healthcare expenditure followed by Europe and Asia Pacific. For instance, in February 2017 Septodont Healthcare India Pvt. Ltd. acquired DLA from Dentsply. The company acquired dental anesthetics such as Citanest (Prilocaine), Mepivalem (Mepivacaine), and Lidostesim (Lidocaine) to the product portfolio. Moreover, this acquisition is expected to strengthen their presence in the Latin American region.


Europe holds the second position in the global dental anesthesia market, owing to the government support for research and development and availability of funds for research. For instance, in September 2017 AstraZeneca, a U.K.-based company signed a collaboration agreement with Aspen Global Incorporated (AGI) for gaining the rights to Aspen’s anesthetic profile outside the U.S. The anesthetic product portfolio includes Xylocard, EMLA, Marcaine, Naropin, Citanest, Carbocaine, and Diprivan. The agreement also implies AstraZeneca for manufacturing and supplying this medication to Aspen Global Incorporated for a period of five years.


Asia Pacific is the fastest growing region owing to the increasing cases of the dental problem and rising patient awareness regarding dental illness. Moreover, the improved lifestyle in growing economies such as China and India is projected to create opportunities in the dental anesthesia market in the Asian regions.


The Middle East and Africa holds the lowest share of the market, owing to limited medical facilities, deprived political conditions in Africa, and less availability of funds.


Key Players


Many key players are undertaking many strategies such as regional expansions, collaborations, divestments, and acquisitions. For instance, in March 2017 GlaxoSmithKline plc divested their anesthetics portfolio to Aspen Pharma. Moreover, GSK’s anesthesia portfolio consists of Nimbex, Tracrium Anectine, Mivacron, and Ultiva. The acquisition of these products has strengthened Aspen’s drug portfolio along with an increased customer base. Additionally, Aspen and GSK have entered into parallel agreements to terminate their collaboration in Africa and further exercise an option to acquire GSK's remaining thrombosis business.       


Some major players in the global dental anesthesia market include Astra Zeneca (UK), Septodont (US), Dentsply (US), Sirona (US), GlaxoSmithKline PLC (US), Gilead Sciences Inc. (US), Johnson & Johnson (US), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), Abbott Laboratories (US), Hospira, Inc. (US), Hikma Pharmaceuticals PLC (UK), AbbVie Inc. (US), Fresenius Se & Co. Kgaa (Germany), and others.



Frequently Asked Questions (FAQ) :


Dental Anesthesia Market is expected to exhibit a strong 8.9% CAGR over the forecast period from 2017 to 2023.

Growing awareness about dental health and the increasing volume of dental procedures is the major driver for the Dental Anesthesia Market.

The unavailability of skilled anesthetists is a key restraint on the Global Dental Anesthesia Market.

The Americas dominate the Global Dental Anesthesia Market.

Leading players in the Global Dental Anesthesia Market include GSK, Dentsply Sirona, and Septodont, among others.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Mode of administration Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Dental Anesthesia Market, by Product Type

6.1 Introduction

6.2 Lidocaine

6.2.1 Market Estimates & Forecast, 2020-2027

6.2.2 Lidocaine 2% with Epinephrine 1:100,000

6.2.2.1 Market Estimates & Forecast, 2020-2027

6.2.3 Lidocaine 2% with Epinephrine 1:50,000

6.2.3.1 Market Estimates & Forecast, 2020-2027

6.2.4 Lidocaine Plain

6.2.4.1 Market Estimates & Forecast, 2020-2027

6.3 Mepivacaine

6.3.1 Market Estimates & Forecast, 2020-2027

6.3.2 Mepivacaine 2% with Levonordefrin 1:20,000

6.3.2.1 Market Estimates & Forecast, 2020-2027

6.3.3 Mepivacaine 3%

6.3.3.1 Market Estimates & Forecast, 2020-2027

6.4 Prilocaine

6.4.1 Market Estimates & Forecast, 2020-2027

6.4.2 Prilocaine 4% with Epinephrine 1:200,000

6.4.2.1 Market Estimates & Forecast, 2020-2027

6.4.3 Prilocaine 4%.

6.4.3.1 Market Estimates & Forecast, 2020-2027

6.5 Articaine

6.5.1 Market Estimates & Forecast, 2020-2027

6.5.2 Articaine 4% with Epinephrine 1:100,00

6.5.2.1 Market Estimates & Forecast, 2020-2027

6.5.3 Articaine 4% with Epinephrine 1:200,000

6.5.3.1 Market Estimates & Forecast, 2020-2027

6.6 Others

Chapter 7. Global Dental Anesthesia Market, by Types of Anesthesia

7.1 Introduction

7.2 General Anesthetics

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Local Anesthetics

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Others

Chapter 8. Global Dental Anesthesia Market, by Mode of Administration

8.1 Introduction

8.2 Maxillary Anesthesia

8.2.1 Market Estimates & Forecast, 2020-2027

8.2.2 Local Infiltration

8.2.2.1 Market Estimates & Forecast, 2020-2027

8.2.2.2 Supraperiosteal Injection

8.2.2.2.1 Market Estimates & Forecast, 2020-2027

8.2.2.3 Intraseptal Injection

8.2.2.3.1 Market Estimates & Forecast, 2020-2027

8.2.2.4 Periodontal Ligament Injection

8.2.2.4.1 Market Estimates & Forecast, 2020-2027

8.2.3 Field Block

8.2.3.1 Market Estimates & Forecast, 2020-2027

8.2.3.2 Supraperiosteal Injection

8.2.3.2.1 Market Estimates & Forecast, 2020-2027

8.2.4 Nerve Block

8.2.4.1 Market Estimates & Forecast, 2020-2027

8.2.4.2 Supraperiosteal Injection

8.2.4.2.1 Market Estimates & Forecast, 2020-2027

8.2.4.3 Intraseptal Injection

8.2.4.3.1 Market Estimates & Forecast, 2020-2027

8.2.4.4 Periodontal Ligament Injection

8.2.4.4.1 Market Estimates & Forecast, 2020-2027

8.3 Mandibular Anesthesia

8.3.1 Market Estimates & Forecast, 2020-2027

8.3.2 Nerve Block

8.3.2.1 Market Estimates & Forecast, 2020-2027

8.2.2.2 IAN

8.2.2.2.1 Market Estimates & Forecast, 2020-2027

8.2.2.3 Akinosi

8.2.2.3.1 Market Estimates & Forecast, 2020-2027

8.2.2.4 Gow-Gates

8.2.2.4.1 Market Estimates & Forecast, 2020-2027

8.4 Others

Chapter 9. Global Dental Anesthesia Market, by End-User

9.1 Introduction

9.2 Specialized Dental Hospitals

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Dental Clinics

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Pharmacies & Drug Stores

9.4.1 Market Estimates & Forecast, 2020-2027

9.5 E-commerce

9.5.1 Market Estimates & Forecast, 2020-2027

9.6 Others

Chapter. 10 Global Dental Anesthesia Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Astra Zeneca

12.1.1 Company Overview

12.1.2 Business Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Septodont

12.2.1 Company Overview

12.2.2 Business Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Dentsply

12.3.1 Company Overview

12.3.2 Business Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Sirona

12.4.1 Company Overview

12.4.2 Business Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 GlaxoSmithKline PLC

12.5.1 Company Overview

12.5.2 Business Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Gilead Sciences Inc.

12.6.1 Company Overview

12.6.2 Business Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Johnson & Johnson

12.7.1 Overview

12.7.2 Business Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 F. Hoffmann-La Roche Ltd.

12.8.1 Company Overview

12.8.2 Business Segment Overview

12.8.3 Financial Overview

12.8.4 Key Development

12.8.5 SWOT Analysis

12.9 Baxter International Inc.

12.9.1 Company Overview

12.9.2 Business Overview

12.9.3 Financial overview

12.9.4 Key Developments

12.10 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical industry

Chapter 14 Appendix


LIST OF TABLES

Table 1 Dental Anesthesia Industry Synopsis, 2020-2027

Table 2 Dental Anesthesia Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Dental Anesthesia Market, by Region, 2020-2027, (USD Million)

Table 4 Dental Anesthesia Market, by Species, 2020-2027, (USD Million)

Table 5 Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 6 Dental Anesthesia Market, by Mode of administration, 2020-2027, (USD Million)

Table 7 Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)

Table 8 North America Dental Anesthesia Market, by Species, 2020-2027, (USD Million)

Table 9 North America Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 10 North America Dental Anesthesia Market, by Mode of Administration, 2020-2027, (USD Million)

Table 11 North America Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)

Table 12 US Dental Anesthesia Market by Species, 2020-2027, (USD Million)

Table 13 US Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 14 US Dental Anesthesia Market, by Mode of Administration, 2020-2027, (USD Million)

Table 15 US Dental Anesthesia Market by, End-User, 2020-2027, (USD Million)

Table 16 Canada Dental Anesthesia Market, by Species, 2020-2027, (USD Million)

Table 17 Canada Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 18 Canada Dental Anesthesia Market, by Mode of Administration, 2020-2027, (USD Million)

Table 19 Canada Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)

Table 20 South America Dental Anesthesia Market, by Species, 2020-2027, (USD Million)

Table 21 South America Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 22 South America Dental Anesthesia Market, by Mode of Administration, 2020-2027, (USD Million)

Table 23 South America Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)

Table 24 Europe Dental Anesthesia Market by Species, 2020-2027, (USD Million)

Table 25 Europe Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 26 Europe Dental Anesthesia Market, by Mode of Administration, 2020-2027, (USD Million)

Table 27 Europe Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)

Table 28 Western Europe Dental Anesthesia Market by Species, 2020-2027, (USD Million)

Table 29 Western Europe Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 30 Western Europe Dental Anesthesia Market, by Mode of administration, 2020-2027, (USD Million)

Table 31 Western Europe Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)

Table 32 Eastern Europe Dental Anesthesia Market, by Species, 2020-2027, (USD Million)

Table 33 Eastern Europe Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 34 Eastern Europe Dental Anesthesia Market, by Mode of Administration, 2020-2027, (USD Million)

Table 35 Eastern Europe Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)

Table 36 Asia Pacific Dental Anesthesia Market, by Species, 2020-2027, (USD Million)

Table 37 Asia Pacific Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 38 Asia Pacific Dental Anesthesia Market, by Mode of Administration, 2020-2027, (USD Million)

Table 39 Asia Pacific Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)

Table 40 The Middle East & Africa Dental Anesthesia Market, by Species, 2020-2027, (USD Million)

Table 41 The Middle East & Africa Dental Anesthesia Market, by Types of Anesthesia, 2020-2027, (USD Million)

Table 42 The Middle East & Africa Dental Anesthesia Market, by Mode of Administration, 2020-2027, (USD Million)

Table 43 The Middle East & Africa Dental Anesthesia Market, by End-User, 2020-2027, (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Dental Anesthesia Market

Figure 3 Segmentation Market Dynamics for Dental Anesthesia Market

Figure 4 Global Dental Anesthesia Market Share, by Species 2020

Figure 6 Global Dental Anesthesia Market Share, by Types of Anesthesia 2020

Figure 7 Global Dental Anesthesia Market Share, by Mode of Administration, 2020

Figure 8 Global Dental Anesthesia Market Share, by End-User, 2020

Figure 9 Global Dental Anesthesia Market Share, by Region, 2020

Figure 10 North America Dental Anesthesia Market Share, by Country, 2020

Figure 11 Europe Dental Anesthesia Market Share, by Country, 2020

Figure 12 Asia Pacific Dental Anesthesia Market Share, by Country, 2020

Figure 13 The Middle East & Africa Dental Anesthesia Market Share, by Country, 2020

Figure 14 Global Dental Anesthesia Market: Company Share Analysis, 2020 (%)

Figure 15 Astra Zeneca: Key Financials

Figure 16 Astra Zeneca: Segmental Revenue

Figure 17 Astra Zeneca: Geographical Revenue

Figure 18 Septodont: Key Financials

Figure 19 Septodont: Segmental Revenue

Figure 20 Septodont: Geographical Revenue

Figure 21 Dentsply : Key Financials

Figure 22 Dentsply : Segmental Revenue

Figure 23 Dentsply : Geographical Revenue

Figure 24 Sirona: Key Financials

Figure 25 Sirona: Segmental Revenue

Figure 26 Sirona: Geographical Revenue

Figure 27 GlaxoSmithKline PLC: Key Financials

Figure 28 GlaxoSmithKline PLC: Segmental Revenue

Figure 29 GlaxoSmithKline PLC: Geographical Revenue

Figure 30 Gilead Sciences Inc.: Key Financials

Figure 31 Gilead Sciences Inc.: Segmental Revenue

Figure 32 Gilead Sciences Inc.: Geographical Revenue

Figure 33 Johnson & Johnson: Key Financials

Figure 34 Johnson & Johnson: Segmental Revenue

Figure 35 Johnson & Johnson: Geographical Revenue

Figure 36 F. Hoffmann-La Roche Ltd.: Key Financials

Figure 37 F. Hoffmann-La Roche Ltd.: Segmental Revenue

Figure 38 F. Hoffmann-La Roche Ltd.: Geographical Revenue

Figure 39 Baxter International Inc.: Key Financials

Figure 40 Baxter International Inc.: Segmental Revenue

Figure 41 Baxter International Inc.: Geographical Revenue